Topic: Biotech
Dr. Moira Gunn learns how the war against cancer has moved from the microscope to the computer from University of California at Santa Cruz professor, David Haussler.
Dr. Moira Gunn gets a glimpse into cabinet meetings at #10 Downing street from UK Minister of State for Universities and Science, David Willetts, and then hosts the annual biotech industry wrap-up with CEO of Burrill & Co, Steve Burrill.
If you had to rely on a medical device implanted into your body to keep you alive, would you trust your life to a closed-source proprietary device manufacturer, or would you rather that it ran on software that was publicly available for review? In sharp, clear tones, Karen tells her story, presenting an entirely new perspective on the importance of open source software. Karen Sandler is the Executive Director of the GNOME foundation and a cyber-lawyer.
Dr. Moira Gunn catches up with Calimmune CEO, Louis Breton and learns how they are looking at treating HIV/AIDS.
Dr. Moira Gunn gets a crash course in identifying biomarkers and what can are doing in personalized medicine from Amgen Vice President for Medical Sciences, David Reese.
Dr. Moira Gunn talks with author and Duke professor, Cathy Davidson about what happens when you hand every incoming Freshmen a free ipod and her new book, Now You See It: How the Brain Science of Attention Will Transform the Way We Live, Work, and Learn.
Dr. Moira Gunn learns how mutations caused cancer from Nobel Prize winner, Michael Bishop and Genetech chairman, Art Levinson.
Dr. Moira Gunn talks about a different way of designing drugs, from anxiety and depression to Type II diabetes, with Addex Pharmaceuticals CEO, Bharatt Chowrira.
Dr. Moira Gunn talks about genetic mutation base being used with autism and tourette's patients from Rutgers University Cell and DNA Repository CEO, Jay Tischfield.
Dr. Moira Gunn talks with Scientific Director from the Stem Cell and Cancer Research Institute at McMaster University, where they have learned how to make blood from skin cells.
